Rarely do consumers in the United States have to give a thought to whether their medicine is counterfeit or real. In the developing world, this issue is a real and present danger. The New York Times published a great piece by Tina Rosenberg on how Sproxil is using readily-available technology to tackle the issue of pharmaceutical counterfeiting.
Read the full article here.